Citadel Advisors’s Definitive Healthcare DH Stock Holding History

Citadel Advisors’s Portfolio DH Stock Details DH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,800	Closed	-$19.7K	–	13025
2025 Q1	$19.7K	Buy	6,800 +2,600	+62%	+$10.6K	﹤0.01%	13158
2024 Q4	$17.3K	Sell	4,200 -1,400	-25%	-$6.12K	﹤0.01%	13262
2024 Q3	$25K	Buy	5,600 +4,900	+700%	+$23K	﹤0.01%	12600
2024 Q2	$3.82K	Sell	700 -4,300	-86%	-$27.1K	﹤0.01%	13545
2024 Q1	$40.4K	Sell	5,000 -400	-7%	-$3.54K	﹤0.01%	12385
2023 Q4	$53.7K	Sell	5,400 -11,700	-68%	-$91.8K	﹤0.01%	11711
2023 Q3	$137K	Sell	17,100 -6,100	-26%	-$61.3K	﹤0.01%	10498
2023 Q2	$255K	Buy	23,200 +12,400	+115%	+$128K	﹤0.01%	9366
2023 Q1	$112K	Buy	10,800 +10,600	+5,300%	+$125K	﹤0.01%	11095
2022 Q4	$2.2K	Buy	+200	New	+$2.57K	﹤0.01%	14370

Other funds holding DH

Advent International Boston, Massachusetts $17.7B AUM 5.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Citadel Advisors's DH Position: Q2 2026 in Review

Citadel Advisors reduced its Definitive Healthcare (DH) stake by 62% in Q2 2026, selling an estimated $245K and leaving 166,291 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #12413.

Citadel Advisors first reported a position in DH in Q3 2021 and has held it in 16 quarters since. The position peaked at $23.2M in Q3 2021. 99 funds tracked by Wall St. Rank hold DH as of Q2 2026.

Citadel Advisors held 166,291 shares of Definitive Healthcare worth $138K as of Q2 2026.
Citadel Advisors sold 267,117 Definitive Healthcare shares in Q2 2026, an estimated $245K.
Definitive Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12413 holding.
Citadel Advisors first reported a position in Definitive Healthcare in Q3 2021 and has held it in 16 quarters since.
Citadel Advisors's Definitive Healthcare position peaked at $23.2M in Q3 2021.
99 funds tracked by Wall St. Rank held Definitive Healthcare as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.